SCHEMBL5817779

SCHEMBL5817779

CNc1nc(-c2cccc(Cl)c2)c(-c2ccnc(NC3CCCC3)n2)s1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 3/20 0.52
CCNT1 O60563 3/20 0.47
CDK9 P50750 3/20 0.47
BRAF P15056 1/20 0.46
EIF2AK2 P19525 1/20 0.46
CDK4 P11802 2/20 0.45
CCND1 P24385 1/20 0.45
MAPK8 P45983 2/20 0.43
MAPK9 P45984 2/20 0.43
MAPK10 P53779 2/20 0.43
IKBKB O14920 2/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
PIK3C3 Q8NEB9 1/20 0.42
MAPK1 P28482 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
MAPK14 Q16539 1/20 0.41
CDK2 P24941 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5815500 0.85 TGFBR1 (0.54) ADORA1BRAFEIF2AK2MAPK8MAPK9
SCHEMBL5823314 0.83 MAPK14 (0.58) ADORA1ADORA3ADORA2AADORA2BMAPK14
SCHEMBL5813731 0.82 ADORA1 (0.49) ADORA1BRAFEIF2AK2CDK4CCND1
SCHEMBL5819447 0.82 ADORA1 (0.49) ADORA1BRAFEIF2AK2CDK4CCND1
SCHEMBL5823374 0.82 ADORA1 (0.53) ADORA1EIF2AK2CDK4CCND1MAPK8
SCHEMBL5817588 0.82 IKBKB (0.54) ADORA1MAPK8MAPK10IKBKBMAPK1
SCHEMBL5815507 0.81 IKBKB (0.53) ADORA1IKBKB
SCHEMBL5813401 0.81 IKBKB (0.53) ADORA1MAPK8MAPK9MAPK10IKBKB
SCHEMBL5819449 0.81 ADORA1 (0.52) ADORA1EIF2AK2CDK4CCND1MAPK8
SCHEMBL5823206 0.81 IKBKB (0.52) ADORA1MAPK8MAPK9MAPK10IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed